Medikit Co (TSE:7749) Cyclically Adjusted Revenue per Share: 円1,352.97 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7749 Medikit Co Ltd TSE:7749
88 GF Score
Price 円2,804.00
GF Value 円3,210.51
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medikit Co Cyclically Adjusted Revenue per Share?

Medikit Co TSE:7749 +0.04% 88 Cyclically Adjusted Revenue per Share is 円1,352.97 as of Mar. 2026. GuruFocus rates TSE:7749 with a GF Score™ of 88/100 and a GF Value™ of 円3,210.51 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medikit Co's adjusted revenue per share for the three months ended in Mar. 2026 was 円364.921. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円1,352.97 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medikit Co's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medikit Co was 8.00% per year. The lowest was 4.70% per year. And the median was 6.20% per year.

As of today (2026-07-29), Medikit Co's current stock price is 円2804.00. Medikit Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円1,352.97. Medikit Co's Cyclically Adjusted PS Ratio of today is 2.07.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medikit Co was 4.34. The lowest was 1.92. And the median was 2.56.


Medikit Co  (TSE:7749) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medikit Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2804.00/1352.97
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medikit Co was 4.34. The lowest was 1.92. And the median was 2.56.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medikit Co Cyclically Adjusted Revenue per Share Related Terms


Medikit Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medikit Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medikit Co Cyclically Adjusted Revenue per Share Chart

Medikit Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,014.92 1,095.30 1,172.21 1,277.57 1,352.97

Medikit Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,277.57 1,298.75 1,316.87 1,345.09 1,352.97

TSE:7749 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Medikit Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medikit Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medikit Co's Cyclically Adjusted PS Ratio falls into.


TSE:7749
88GF Score
Medikit Co Ltd TSE:7749
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medikit Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medikit Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=364.921/112.7000*112.7000
=364.921

Current CPI (Mar. 2026) = 112.7000.

Medikit Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 246.611 98.100 283.314
201609 248.170 98.000 285.396
201612 265.717 98.400 304.332
201703 233.328 98.100 268.054
201706 256.045 98.500 292.957
201709 252.995 98.800 288.588
201712 286.548 99.400 324.889
201803 233.340 99.200 265.095
201806 262.382 99.200 298.089
201809 272.558 99.900 307.480
201812 304.834 99.700 344.582
201903 251.427 99.700 284.211
201906 293.803 99.800 331.780
201909 296.458 100.100 333.774
201912 323.155 100.500 362.384
202003 259.879 100.300 292.008
202006 281.279 99.900 317.319
202009 286.338 99.900 323.026
202012 311.097 99.300 353.078
202103 264.203 99.900 298.055
202106 294.358 99.500 333.409
202109 301.202 100.100 339.116
202112 328.863 100.100 370.258
202203 273.737 101.100 305.145
202206 315.559 101.800 349.347
202209 313.848 103.100 343.071
202212 350.643 104.100 379.611
202303 307.320 104.400 331.753
202306 330.628 105.200 354.199
202309 315.305 106.200 334.603
202312 358.134 106.800 377.919
202403 333.772 107.200 350.896
202406 380.341 108.200 396.159
202409 382.189 108.900 395.525
202412 410.198 110.700 417.609
202503 353.733 111.100 358.827
202506 402.931 111.700 406.538
202509 412.577 112.000 415.156
202512 448.441 113.000 447.250
202603 364.921 112.700 364.921

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円1,352.97 mean?
Medikit Co (TSE:7749) has a Cyclically Adjusted Revenue per Share of 円1,352.97 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medikit Co and its competitors.
Is Medikit Co's Cyclically Adjusted Revenue per Share too high?
Medikit Co's current Cyclically Adjusted Revenue per Share is 円1,352.97. Overall, Medikit Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Medikit Co's Cyclically Adjusted Revenue per Share of 円1,352.97 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medikit Co and its competitors. Medikit Co's current Cyclically Adjusted Revenue per Share is 円1,352.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,210.51, compared to a current price of 円2,804.00 — trading 12.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円1,352.97. Medikit Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Cyclically Adjusted Revenue per Share is 円1,352.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medikit Co (TSE:7749) Overvalued in 2026?

Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued. The current stock price of 円2,804.00 is trading 12.7% below its estimated GF Value™ of 円3,210.51. GuruFocus considers Medikit Co to be Modestly Undervalued.

Key valuation signals for TSE:7749:

  • Cyclically Adjusted Revenue per Share: 円1,352.97
  • GF Value™: 円3,210.51 vs. price of 円2,804.00 (12.7% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medikit Co Business Description

Address 1-13-2 ,Yushima, Bunkyo-Ku, Tokyo, JPN, 113 0034
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
88GF Score

Get the complete analysis for TSE:7749

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,804.00
Price
円3,210.51
GF Value